• Advertise
  • Contact Us
  • Write For Us
  • Our Team
Extraction Magazine
No Result
View All Result
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
  • Botanical Extraction
    • Cannabinoids
    • Psychedelics
    • Nutraceutical
    • Product Refinement
  • Industry News
    • Business
    • Sustainability
    • Safety & Compliance
    • Partners
  • Extraction Technology
    • Equipment
    • Methods
    • Solvents
    • DIY Extraction
    • Analytical Techniques
  • Medical Research
  • Glossary
  • Business Directory
No Result
View All Result
Extraction Magazine
No Result
View All Result
Home Industry News

Safety Concerns Surrounding New Cannabinoid Products

Asia Mayfield by Asia Mayfield
October 24, 2021
in Industry News
Safety Concerns Surrounding New Cannabinoid Products

Consumer interest in delta-8-tetrahydrocannabinol (THC) remains high. However, many regulators and health officials across the country believe that the cannabinoid poses a public safety risk.

“My concern is that we have no idea what these products are,” Christopher Hudalla, president and chief scientific officer of ProVerde Laboratories, told Chemical & Engineering News. “So far, I have not seen one that I would consider a legitimate delta-8-THC product.”

READ ALSO

If FDA Takes Control, Will Cannabis Processors Need GMP Certification?

Which Hemp Products Face the Greatest Regulatory Uncertainty?

Most delta-8 products sold in the U.S. are not subject to the same testing requirements and regulations as typical delta-9-THC products. This is because delta-8 (and delta-9) can be derived from federally legal hemp and the cannabidiol (CBD) therein.

Questions about delta-8’s safety center around the unregulated market. Anyone can sell delta-8 in most states, and there’s no guarantee that the product will be labeled correctly.

Delta-8-THC is surging in popularity, but it’s not the only cannabinoid chemists can create in a lab. For example, using chromatography with ultraviolet or mass spectrometry detection, scientists tested delta-8 products on the market. They determined that while there was usually delta-8-THC present, they also detected the presence of other, lesser-known compounds like delta-10-THC.

It’s not necessarily the actual cannabinoids that pose the safety risks, and time combined with scientific investigation will determine whether that holds true. Rather, it’s the chemical processes used in creating the cannabinoids, as well as byproducts that can be formed, that cause distress.

“I’m less concerned with traditional THC isomers than I am of the ubiquitous unknowns,” says Michael Coffin, chief scientist at cannabis manufacturing firm Elevation Distro, in the Chemical & Engineering News article.

“Delta-8, delta-9, and even delta-10 don’t seem to have any ill effects on people that we know of at this point… But a lot of people are doing a poor job of cleaning up their reaction products.”

The reason why this is important is that it takes chemical reactions to create or synthesize these THC isomers. For example, a strong acid can be used to transform CBD into delta-9- and delta-8-THC, but these reactions are not perfect, and are highly dependent on the conditions used. Chromatographic methods like supercritical fluid chromatography can clean up impurities in the samples, thereby refining end products before they reach consumers.

For many, the problems with delta-8 and other derived cannabinoids could be solved by simple regulations. In Oregon, for example, delta-8 products must be sold through the state’s legal cannabis market. This forces delta-8 manufacturers to comply with stricter rules, and ensures that the products are subjected to the same lab testing required for other cannabis products.

 

Image source: elsaolofsson, CC BY 2.0 via Wikimedia Commons

Related Posts

Commercial cannabis cultivation facility with rows of plants beneath a greenhouse-style roof and overhead structural systems.
Industry News

If FDA Takes Control, Will Cannabis Processors Need GMP Certification?

October 13, 2026
Hemp-derived CBD oils, topical creams, capsules, and other cannabinoid wellness products arranged on a pink surface.
Industry News

Which Hemp Products Face the Greatest Regulatory Uncertainty?

October 9, 2026
Hemp-derived CBD oil and topical product containers displayed with hemp leaves on a wooden platform
Industry News

What Happens if Hemp-Derived THC Products Face New Federal Restrictions?

October 6, 2026
Large-scale hemp cultivation facility with rows of cannabis plants under greenhouse lighting
Botanical Extraction

How the 2018 Farm Bill Created Today’s Hemp Industry

October 6, 2026
Cannabis leaves and cookies representing cannabinoid-infused consumer food products
Botanical Extraction

Could FDA Become the Primary Regulator of Consumable Cannabinoids?

October 2, 2026
AI-powered cannabis cultivation system optimizing terpene and cannabinoid production with real-time data analytics
Business

How AI-Designed Formulas Just Cracked the $2.3B Terpene Code

July 14, 2025
Next Post
Gutenberg’s Dank Pressing Co. Review

Gutenberg's Dank Pressing Co. Review

Sitemap

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.

No Result
View All Result
  • Industry News
  • Botanical Extraction
  • Medical Research
  • Medical Research
  • Glossary
  • Our Team
  • Write For Us

© 2026 Extraction Magazine is the trusted provider of botanical extraction news and the leading media in the ever-changing extraction industry.